Contrary to previous research paradigms about adiponectin, our results did not show a statistically significant role in predicting the development of MetS in T2DM participants, which could be attributed to the fact that the level of serum adiponectin concentration might be influenced by other metabolic factors (e.g., adipocytes’ turnover rate). Here, ADIPOQ is linked to metabolic syndrome.